Analysis identifies critical defects in orthopedic implants, suggesting improvements through quality techniques.
General Background: Product quality plays a crucial role in influencing consumer decisions, particularly in the medical device industry. Specific Background: PT XYZ is a manufacturer of orthopedic and traumatology implants, where even minor defects can have serious implications. Knowledge Gap: However, limited research has been conducted on identifying and mitigating product defects within this specific manufacturing context using integrated quality improvement methods. Aims: This study aims to evaluate the level and causes of product defects in order to provide targeted recommendations for quality enhancement. Results: The analysis revealed that the most frequent defect occurred in the hole diameter of the implant, with a total of 455 defective units. The process had a Defects Per Million Opportunities (DPMO) of 33,343 and an average sigma level of 3.33. The primary cause was the imprecise initial dimensions of the plate, resulting in a Fuzzy Risk Priority Number (FRPN) of 3.82. Novelty: The study uniquely integrates Six Sigma and Fuzzy Failure Mode and Effects Analysis (FMEA) to prioritize and address quality risks in a high-stakes manufacturing environment. Implications: It is recommended to implement raw material inspection prior to production to reduce defect rates and advance toward zero-defect manufacturing. Highlights: Identified critical defect in implant hole diameter. Integrated Six Sigma and Fuzzy FMEA for risk prioritization. Recommended raw material checks to reduce defects.
No takes yet. Share an insight, caveat, or question.
Rizkyllah et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: